 "Zydus Gains FDA Approval for Scopolamine Patch, Tapping .6M Market")
Zydus Lifesciences Ltd has secured final approval from the US FDA to Market its Scopolamine transdermal system, designed to prevent nausea and vomiting in various situations, including after surgery and due to motion sickness. The product, which delivers 1 mg over 3 days, will be manufactured at Zydus’ facility in Ahmedabad. This marks the fifth ...
The FDA has granted approval to Amgen for their groundbreaking new treatment, Imdeltra™ (tarlatamab-dllE), making it the first and only T-cell engager therapy available for extensive-stage small cell lung cancer. This innovative therapy offers hope for patients battling this aggressive form of cancer, providing a much-needed treatment option for those in need. Click to Claim ...
The Food and Drug Administration (FDA) has put forth a proposal to prohibit the use of formaldehyde in hair relaxers, citing potential health risks. However, the agency has missed its own deadline to make a final decision on the matter. The chemical, commonly found in many hair products, has been linked to various health concerns ...
